Joseph J. LaRosa
2021
In 2021, Joseph J. LaRosa earned a total compensation of $7.1M as Executive Vice President, General Counsel and Secretary at Regeneron Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $916,110 |
|---|---|
| Option Awards | $3,227,316 |
| Salary | $810,000 |
| Stock Awards | $2,151,475 |
| Other | $22,000 |
| Total | $7,126,901 |
LaRosa received $3.2M in option awards, accounting for 45% of the total pay in 2021.
LaRosa also received $916.1K in non-equity incentive plan, $810K in salary, $2.2M in stock awards and $22K in other compensation.
Rankings
In 2021, Joseph J. LaRosa's compensation ranked 1,704th out of 12,415 executives tracked by ExecPay. In other words, LaRosa earned more than 86.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,704 out of 12,415 | 86th |
Division Manufacturing | 629 out of 5,505 | 89th |
Major group Chemicals And Allied Products | 232 out of 2,375 | 90th |
Industry group Drugs | 195 out of 2,096 | 91st |
Industry Pharmaceutical Preparations | 132 out of 1,546 | 92nd |
Source: SEC filing on April 21, 2022.
LaRosa's colleagues
We found five more compensation records of executives who worked with Joseph J. LaRosa at Regeneron Pharmaceuticals in 2021.
2021
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
2021
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2021
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2021
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2021
George Yancopoulos
Regeneron Pharmaceuticals